Neuroblox

Neuroblox

Private
Stony Brook, New YorkHealthcare & Life Scienceshttps://www.neuroblox.ai/

Last Round

Accelerator

Feb 24, 2025

Total Funding Raised

$3.2M

Company Overview

Neuroblox is a biotechnology and software company that provides a multiscale, mechanistic neural circuit simulation platform for designing and testing neurotherapeutics in silico.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

neural circuit simulationcomputational neurosciencein silico drug developmentbrain simulation softwaremechanistic modelingbrain digital twinneurotherapeuticsscientific machine learningin silico clinical trialsmultiscale modelingAI drug discoverypre-clinical validationin silico experimentationneuroCADsimulation-based inference

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuroblox Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neuroblox Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 24, 2025
GrantMay 8, 2023

Key People

Founding team and executive leadership

Lilianne Mujica-Parodi

Chief Executive Officer

Executive Team

Neuroblox Investors

Notable investors and investment history

InvestorRounds
Baszucki GroupGrant
One Mind AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2025

    Received funding from One Mind Accelerator.

  • May 8, 2023

    $3.2M grant round led by Baszucki Group.

Neuroblox Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuroblox Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuroblox's valuation, stock price, and market status.

Firmographic Details

HeadquartersStony Brook, New York
Employee Range10
Year Founded2023
Last FundingFeb 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.